iTeos’ Discovery Process

  • Discover new mechanisms that cancer cells use to avoid immune recognition and attack by targeting immunometabolism and immunosuppressive cells in the tumor micro-environment
  • Leverage our expertise in small molecule and monoclonal antibody drug development to discover medicines to reverse these newly described mechanisms
  • Build upon our expertise in tumor biology, immunology, drug discovery and early clinical development to provide new and effective therapies for persons with cancer